CHENNAI PRESS NEWS

Chennai, India | 4 February 2025: MrMed, a direct-to-patient platform for critical care and super-specialty medicines, today announced a new phase of accelerated growth, backed by expanded physical infrastructure, enhanced cold-chain capabilities, and a growing national footprint. (L to R) Devashish Singh, Co-founder & CEO, MrMed; Saurab Jain, Co-founder, MrMed Underscoring its commitment to timely access to life-saving and temperature-sensitive medicines, MrMed has strengthened its on-ground presence with new operations in Guwahati, complementing its existing infrastructure in Chennai, Delhi, and Bengaluru. The expansion is designed to improve last-mile delivery and significantly reduce fulfilment timelines across regions. Press meet Youtube Video link 👇  As part of this phase, MrMed has also launched an offline cold-chain storage facility in Bengaluru, reinforcing the city’s position as a strategic fulfilment hub for Karnataka and the wider South India region. Chen...

Chennai, 4th February 2026: ICL Fincorp has announced the launch of its latest public issue of Secured Redeemable Non-Convertible Debentures (NCDs), opening on 5th February 2026, offering investors an effective yield of up to 12.25%. Designed to suit diverse investment needs, the issue provides flexible tenure and interest payout options, making it a compelling opportunity for investors seeking stable and secure returns. (L to R) T.V.Visakh Company Secretary; HE Hon. Adv. K. G. Anilkumar, CMD, ICL Fincorp Ltd / Goodwill Ambassador, LACTC; Madhavankutty. T, Chief Finance Officer  Buoyed by the overwhelming response to its earlier NCD offerings, ICL Fincorp expressed gratitude to its investors for their continued trust and confidence. This strong support reinforces the company’s commitment to delivering robust, customer-focused financial solutions that evolve with investor expectations. Press meet Youtube Video link 👇  The NCD issue will remain open until 18th Februar...